|
Volumn 68, Issue 10, 2000, Pages 6073-6076
|
Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
GAMMA INTERFERON;
MYCOBACTERIUM ANTIGEN;
MYCOBACTERIUM ANTIGEN ESAT 6;
TUBERCULIN;
UNCLASSIFIED DRUG;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
HUMAN;
HUMAN CELL;
IMMUNOCOMPETENT CELL;
PRIORITY JOURNAL;
SEROCONVERSION;
TUBERCULOSIS;
AMINO ACID SEQUENCE;
ANTIGENS, BACTERIAL;
BCG VACCINE;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HUMAN;
INTERFERON TYPE II;
LEUKOCYTES, MONONUCLEAR;
MOLECULAR SEQUENCE DATA;
MYCOBACTERIUM TUBERCULOSIS;
SUPPORT, NON-U.S. GOV'T;
TUBERCULIN;
TUBERCULOSIS, PULMONARY;
VACCINATION;
|
EID: 0033806210
PISSN: 00199567
EISSN: None
Source Type: Journal
DOI: 10.1128/IAI.68.10.6073-6076.2000 Document Type: Article |
Times cited : (68)
|
References (19)
|